hydroxyindoleacetic acid has been researched along with Adenoma, beta-Cell in 2 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Toole, D | 1 |
| Grossman, A | 1 |
| Gross, D | 1 |
| Delle Fave, G | 1 |
| Barkmanova, J | 1 |
| O'Connor, J | 1 |
| Pape, UF | 1 |
| Plöckinger, U | 1 |
| Blanchin, M | 1 |
| James-Deidier, A | 1 |
| Chaumet-Riffaud, PD | 1 |
| Chayvialle, JA | 1 |
1 trial available for hydroxyindoleacetic acid and Adenoma, beta-Cell
| Article | Year |
|---|---|
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Female; France; Gastrinoma; Glucagonoma; Humans; Hydroxyindoleacetic | 1992 |
1 other study available for hydroxyindoleacetic acid and Adenoma, beta-Cell
| Article | Year |
|---|---|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
Topics: Biomarkers; Chromogranin A; Fasting; Gastrinoma; Humans; Hydroxyindoleacetic Acid; Hypoglycemia; Ins | 2009 |